TB day summit in upstate New York: Key issues to address

In recognition of World TB day (March 24), tuberculosis (TB) experts from New York State and vicinity met to discuss scientific progress and how it can impact control of TB. The meeting was held in Saranac Lake where Dr. E. L. Trudeau first cultured Mycobacterium tuberculosis (Mtb) following the guidelines of Dr. Koch and also where Trudeau set up his successful TB sanitarium (Fig. 1). Many attendees were excited to visit this historical center of TB research and treatment however, they left with a profound sense of how much there remains to be done in order to bring TB under control. The majority of the meeting was in a workshop format with speakers providing a 15-min presentation of their recent work in three scientific sessions. The first session was entitled ‘‘Mycobacterium tuberculosis: a potent pathogen’’, the second was ‘‘Tuberculosis: the nature of the human disease’’ and the third was ‘‘Cellular Immunity to tuberculosis: from animal models to human disease’’. At the end of these scientific sessions, a final open discussion session was held entitled ‘‘Vaccination, Drugs and Public Health: the trifecta of tuberculosis control worldwide’’. This consisted of a focused discussion of what is required to improve vaccination, drug development and public health. The meeting was opened with a poem written by a student in 1908 in honor of Dr. E. L. Trudeau’s 60th birthday. Dr. Trudeau started the Trudeau sanitarium and research facilities in Saranac Lake 125 years ago and his legacy lives on in the Trudeau Institute where the meeting was held. Mtb: a potent pathogen In the first session, the speakers stressed the importance of understanding the basic biology of mycobacteria in order to identify new drug targets and facilitate rational drug design. Using a variety of genetic tools, the speakers highlighted how mycobacteria communicate with Figure 1. The images show: Dr. E. L. Trudeau performing research on Mtb in his ‘‘state of the art’’ laboratory (top left); Dr. E. L. Trudeau’s son examining a TB patient (top right); and a number of TB patients taking the ‘‘New Winter Cure’’ at the Trudeau Cottage Sanitarium in 1889 (bottom). The TB Summit that took place in 2009 held its social evening in the newly restored TB laboratories used by Dr. E. L. Trudeau. Images courtesy of the Trudeau Institute Archive.

[1]  P. Gros,et al.  Genetic and Functional Characterization of the Mouse Trl3 Locus in Defense against Tuberculosis1 , 2009, The Journal of Immunology.

[2]  K. McDonough,et al.  Rv1675c (cmr) regulates intramacrophage and cyclic AMP‐induced gene expression in Mycobacterium tuberculosis‐complex mycobacteria , 2009, Molecular microbiology.

[3]  J. Casanova,et al.  Inborn errors of interferon (IFN)‐mediated immunity in humans: insights into the respective roles of IFN‐α/β, IFN‐γ, and IFN‐λ in host defense , 2008, Immunological reviews.

[4]  Gábor Balázsi,et al.  The temporal response of the Mycobacterium tuberculosis gene regulatory network during growth arrest , 2008, Molecular systems biology.

[5]  M. Glickman,et al.  Delayed protection by ESAT-6–specific effector CD4+ T cells after airborne M. tuberculosis infection , 2008, The Journal of experimental medicine.

[6]  B. Kreiswirth,et al.  Lessons from molecular epidemiology and comparative genomics. , 2008, Seminars in respiratory and critical care medicine.

[7]  Alan D. Roberts,et al.  ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes , 2008, Proceedings of the National Academy of Sciences.

[8]  K. Derbyshire,et al.  The specialized secretory apparatus ESX‐1 is essential for DNA transfer in Mycobacterium smegmatis , 2008, Molecular microbiology.

[9]  G. Kaplan,et al.  Bacillus Calmette-Guérin Vaccination of Human Newborns Induces T Cells with Complex Cytokine and Phenotypic Profiles1 , 2008, The Journal of Immunology.

[10]  W. Hillen,et al.  In vivo gene silencing identifies the Mycobacterium tuberculosis proteasome as essential for the bacteria to persist in mice , 2007, Nature Medicine.

[11]  Barun Mathema,et al.  Molecular Epidemiology of Tuberculosis: Current Insights , 2006, Clinical Microbiology Reviews.

[12]  G. Kaplan,et al.  The effect of bacille Calmette-Guérin vaccine strain and route of administration on induced immune responses in vaccinated infants. , 2006, The Journal of infectious diseases.

[13]  L. Myer,et al.  Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design , 2005, AIDS.